No Detail Found!

Inhibiting toll-like receptors: a comprehensive review of emerging strategies and potential therapeutic implications

Author(s)
Shahana Wahid Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Sana Ali Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Shumaila Qadir Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Darakhshan Amin Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Saima Jameel Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Rabia Asif Department of Pharmacy, Suleman Roshan Medical College Tandoadam,,Pakistan
Nausheen Hameed Siddiqui Department of Pharmacy, Benazir Bhutto Shaheed University, Lyari, Karachi, Pakistan
Abstract
Toll-like receptors (TLRs) mediate the inflammatory response by synthesizing and activating various proinflammatory mediators through innate immunity. Irrationally TLRs over activation disrupt homeostasis that in turn overproduces cytotoxic cytokines. All such events subsequently enhance the progression of numerous immune system-related disorders. For instance, the overexpression of TLRs is now considered the basis of sepsis, endotoxemia, rheumatoid arthritis, acute kidney injury, acute lung injury, systemic lupus erythematosis, and cardiovascular diseases. The normal physiological pathways of TLRs, as well as some TLR4 inhibitors, are discussed in this review. These drug mixtures range from ordinary small molecular compounds to soothing biologics and nano devices. Specifically, these are either synthesized or obtained from natural resources. Natural TLR4 antagonism has wide therapeutic applications and various synthetic and natural metabolites are under excessively testing involving drug discovery. Nanoparticles are arising as a drug delivery system for powerful TLRs inhibitors of their notable properties for the improvement in bioavailability, supported course, and favored pharmacodynamic and pharmacokinetic profiles. All things considered, these discoveries and continual investigations of TLRs antagonism might change the pharmacological management of various diseases.
Publication Details
Page(s) 156-167
DOI DOI not available
Published Journal: International Journal of pathology, Volume: 21, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
TLR4 receptors antagonist, Natural metabolites., signaling pathways, Toll receptors
0

Citations

0

Downloads

23

Views